Search Results 1841-1850 of 14774 for anti-TNF drugs

  1. Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir (Oral Route) Precautions - Mayo Clinic

    These reactions are more common if you are female, obese, or have been taking anti-HIV medicines for a long time. Call your doctor right away if you have ...

  2. Mayo Clinic Bone Marrow Transplant Program Archives

    ... treatment options for MS. Also on the program, cardiologist Dr. Rekha Mankad explains why caution should be used when taking nonsteroidal anti-inflammatory ...

  3. Tetracycline (Class) (Oral Route, Parenteral Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Adoxa; Adoxa CK; Adoxa Pak; Brodspec; Cleeravue-M ...

  4. Emtricitabine (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Tetracycline (Topical Application Route) Proper Use - Mayo Clinic

    However, to help keep your acne under control, keep using this medicine for the full time of treatment, even if your symptoms begin to clear up after a few days ...

  6. COPD Clinical Trials - Mayo Clinic Research

    We hypothesize that supplementation with L-carnitine that is available both as an FDA-approved therapy for primary carnitine deficiency, as well as widely ...

  7. A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies (ARASTEP) - Mayo Clinic

    A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate ...

  8. Nalbuphine (Injection Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  9. Loncastuximab Tesirine in WM - Mayo Clinic

    the Second International Workshop on Waldenström macroglobulinemia. - At least 2 prior lines of treatment, including an anti-CD20 monoclonal antibody ...

  10. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

    system disease. 3. Anti-cancer therapy, such as chemotherapy, immunotherapy, hormonal therapy, targeted therapy, or investigational agents within five half ...